Upgrade to SI Premium - Free Trial

Evoke Pharma (EVOK) Tops Q4 EPS by 20c

March 4, 2015 4:22 PM

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.48), $0.20 better than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

Categories

Earnings

Next Articles